Leadless pacemaker implantation after lead extraction for cardiac implanted electronic device infection

Affiliations

¹ Department of Cardiovascular Diseases, Vanderbilt University, Nashville, Tennessee, USA.
² Vanderbilt Heart and Vascular Institute, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Editorial

Jamie Kowal et al. J Cardiovasc Electrophysiol. 2022 Mar.

. 2022 Mar;33(3):471-472.

doi: 10.1111/jce.15366. Epub 2022 Jan 31.

¹ Department of Cardiovascular Diseases, Vanderbilt University, Nashville, Tennessee, USA.
² Vanderbilt Heart and Vascular Institute, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

No abstract available

Keywords: lead extraction and pacemaker infection.

References

1. Kusumoto FM, Schoenfeld MH, Wilkoff BL, et al. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm. 2017;14(12):e503-e551.
1. Le KY, Sohail MR, Friedman PA, et al. Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections. Heart Rhythm. 2011;8(11):1678-1685.
1. Kusumoto FM, Schoenfeld MH, Wilkoff BL, et al. Leadless pacemaker implant in patients with pre-existing infections: results from the Micra postapproval registry. J Cardiovasc Electrophysiol. 2019;30(4):569-574.
1. Le KY, Sohail MR, Friedman PA, et al. Leadless pacemaker implantation after explantation of infected conventional pacemaker systems: a viable solution? Heart Rhythm. 2019;16(1):66-71.
1. El-Chami MF, Johansen JB, Zaidi A, et al. Concomitant leadless pacemaker implantation and lead extraction during an active infection. J Cardiovasc Electrophysiol. 2020;31(4):860-867.